基于RGD的自组装纳米药物,用于改善瘤治疗.
Bin Wang1, Dongmei Tang2, Jianqiao Cui2
1Department of Sports Medicine, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Frontiers in pharmacology
|October 16, 2024
概括
基于RGD的纳米药物通过改善药物输送和减少副作用,显示出针对性癌症治疗的前景. 需要进一步的研究来克服临床使用的挑战.
科学领域:
- 纳米技术纳米技术
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
背景情况:
- 向性癌症治疗旨在提高治疗疗效和减少全身毒性.
- 纳米技术为药物输送提供了新的平台,提高了治疗结果.
- RGD是向整合素的配体,通常在瘤细胞上过度表达.
研究的目的:
- 探索基于RGD的自组装纳米药物的潜力,以增强癌症治疗.
- 审查与基于RGD的纳米药物开发相关的优势和挑战.
- 概述临床翻译的未来研究方向.
主要方法:
- 使用RGD的纳米结构的自组装.
- 纳米颗粒对稳定性和药物负载的表征.
- 在体外和体内研究瘤向和细胞吸收评估.
- 对治疗疗效和安全性概况的评估.
主要成果:
- 基于RGD的纳米药物证明了增强瘤向和细胞吸收.
- 自组装的纳米结构促进了高效和稳定的药物输送.
- 与传统疗法相比,观察到较少的脱效应.
- 确定的主要挑战包括免疫性,稳定性,瘤异质性和制造可扩展性.
结论:
- 基于RGD的自组装纳米药物代表了针对性癌症治疗的重大进步.
- 解决生物相容性,向和制造方面的挑战对于临床成功至关重要.
- 专注于个性化医疗和创新技术的未来研究将加速翻译.
- 这些纳米药物具有更有效,更安全的癌症治疗的潜力.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160